Combinatorx website screenshot

Combinatorx

CombinatoRx, Inc. was a Cambridge/Boston, Massachusetts biopharmaceutical company (SEC CIK 0001135906, SIC 2834 Pharmaceutical Preparations, incorporated in Delaware) that pursued combination drug discovery — screening pairs of approved drugs for synergistic therapeutic effects. It registered with the SEC in 2002 and traded publicly following its 2005 IPO. The company was renamed Zalicus Inc. in September 2010 after its combination with Neuromed Pharmaceuticals, and renamed again to EPIRUS Biopharmaceuticals, Inc. in July 2014 after merging with EPIRUS. EPIRUS was delisted in September 2016 (Form 25-NSE) and its SEC registration was formally revoked on 2024-05-14. The company is defunct: it operated no developer program and published no public API, SDK, or developer documentation, and combinatorx.com is now a parked NameBright listing unrelated to the original company. This profile is retained as a historical record of a Canaan Partners portfolio company and has no API surface to catalog.

Combinatorx is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Pharmaceuticals, Drug Discovery, and Life Sciences.

0 APIs
CompanyBiotechnologyPharmaceuticalsDrug DiscoveryLife SciencesHealthcareDefunctVenture Backed

Resources

Other 1

Properties that don't map to a standard resource type

Source (apis.yml)

apis.yml Raw ↑
aid: combinatorx
deliveryModel:
  model: unknown
  open_source: false
  commercial: false
  callable_host: false
  label: Delivery model not determined — needs a product licence on record
  confidence: low
  source:
  - none
  generated: '2026-08-28'
  method: derived
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/combinatorx.png
name: Combinatorx
description: 'CombinatoRx, Inc. was a Cambridge/Boston, Massachusetts biopharmaceutical company (SEC CIK 0001135906, SIC 2834
  Pharmaceutical Preparations, incorporated in Delaware) that pursued combination drug discovery — screening pairs of approved
  drugs for synergistic therapeutic effects. It registered with the SEC in 2002 and traded publicly following its 2005 IPO.
  The company was renamed Zalicus Inc. in September 2010 after its combination with Neuromed Pharmaceuticals, and renamed
  again to EPIRUS Biopharmaceuticals, Inc. in July 2014 after merging with EPIRUS. EPIRUS was delisted in September 2016 (Form
  25-NSE) and its SEC registration was formally revoked on 2024-05-14. The company is defunct: it operated no developer program
  and published no public API, SDK, or developer documentation, and combinatorx.com is now a parked NameBright listing unrelated
  to the original company. This profile is retained as a historical record of a Canaan Partners portfolio company and has
  no API surface to catalog.'
url: https://raw.githubusercontent.com/api-evangelist/combinatorx/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- canaan-partners
x-tier: stub
x-tier-reason: defunct-no-api-surface
x-status: defunct
x-successor: EPIRUS Biopharmaceuticals, Inc.
x-former-names:
- name: COMBINATORX INC
  from: '2002-09-12'
  to: '2004-02-26'
- name: COMBINATORX, INC
  from: '2004-12-10'
  to: '2010-08-10'
- name: Zalicus Inc.
  from: '2010-09-09'
  to: '2014-07-02'
specificationVersion: '0.23'
created: '2026-07-17'
modified: '2026-07-20'
tags:
- Company
- Biotechnology
- Pharmaceuticals
- Drug Discovery
- Life Sciences
- Healthcare
- Defunct
- Venture Backed
apis: []
common:
- type: SECFilings
  name: SEC EDGAR filings (CIK 0001135906)
  url: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001135906&type=10-K&dateb=&owner=include&count=40
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-20'
  status: nochange
  artifacts_added: 0
  pass: local-v1
  notes: 'Company confirmed defunct via SEC EDGAR (CIK 0001135906): CombinatoRx -> Zalicus (2010) -> EPIRUS Biopharmaceuticals
    (2014), delisted 2016-09-26, registration revoked 2024-05-14. No API, SDK, package, GitHub org, or developer surface exists.
    combinatorx.com resolves to a parked NameBright page whose catch-all returns 200 for every path, so the /.well-known/security.txt
    and /llms.txt hits are not real artifacts and were not saved. No artifacts written.'

Work with this as data

Every provider here is available over the APIs.io API and to AI agents over MCP.

MCP server

One button, every client — Claude, Cursor, VS Code and the rest.

https://apis.io/mcp

Tools for providers

9 MCP tools reach this
  • find_providersBrowse and filter every provider in the catalog.
  • get_provider_artifactsEvery artifact this provider publishes, grouped by type.
  • get_provider_operationsEvery operation across all of their OpenAPIs — one call instead of parsing every spec.
  • get_provider_toolsEvery MCP tool they ship, with the operation each wraps.
  • get_provider_evidenceHow each part of their score was established. Free — the basis for a claim should not sit behind it.
  • get_provider_ratingPRO — composite, band, trend and facet scores.
  • apis_io_searchSTART HERE — APIs, providers and tags for one query, each with its total.
  • resolveTurn a domain, URL or GitHub org into the provider it belongs to.
  • find_cohortsEvery scored population of providers in the catalog.
All 92 tools →

Call it yourself

curl for this page
This provider
curl "https://apis.io/api/v1/providers/combinatorx"
All providers
curl "https://apis.io/api/v1/providers?limit=25"
Every operation they expose
curl "https://apis.io/api/v1/providers/combinatorx/operations?limit=25"
How their score was established
curl "https://apis.io/api/v1/providers/combinatorx/evidence"

Discovery needs no key. Ratings and market analysis are Pro.

Get an API key

Free tier, no form to fill in. Signing in shares your email address with us — we store it to create your key and to recognise you if you sign in with another provider. See our Privacy Policy and Terms.

A second provider on the same verified email joins the account you already have.